Background

Portfolio

The quality and scale of Royalty Pharma’s portfolio of pharmaceutical royalties is unparalleled in the industry. Starting in 1996, we have meticulously acquired royalty interests in many of the industry’s leading drugs by sales that address serious unmet medical needs and improve the lives of patients around the world.

Product
Marketer
2017 Sales
($, Millions)
Top
indications
Year of
Acquisition
Status at
Acquisition
Royalty
Seller